SFX by Ex Libris Inc.

Title:	Episodic Nucleotide Substitutions in Seasonal Influenza Virus H3N2 Can Be Explained by Stochastic Genealogical Process without Positive Selection
Source:	Molecular Biology and Evolution [0737-4038] Kim, K yr:2015

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Filippini, F. "Comparative structural analysis of haemagglutinin proteins from type A influenza viruses: conserved and variable features." BMC bioinformatics 15.1 (2014): 363-.
description	2.	Koel, Björn F. "Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution." Science 342.6161 (2013): 976-979.
description	3.	Wang, Y. "The haemagglutinin of Avibacterium paragallinarum is a trimeric autotransporter adhesin that confers haemagglutination, cell adherence and biofilm formation activities." Veterinary microbiology 174.3-4 (2014): 474-482.
description	4.	Ahmed, Muhammad S. "Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection." Antiviral research 114 (2015): 106-112.
description	5.	Taubenberger, J. "Influenza Virus Evolution, Host Adaptation, and Pandemic Formation." Cell Host & Microbe 7.6 (2010): 440-451.
description	6.	Webster, R G G. "Immunity to influenza in the elderly." Vaccine 18.16 (2000): 1686-9.
description	7.	Bull, Jim, D. "Virus evolution: Epidemics-in-waiting." Nature 426.6967 (2003): 609-10.
description	8.	Wiley, D C C. "Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation." Nature 289.5796 (1980): 373-8.
description	9.	Ferguson, N. "Ecological and immunological determinants of influenza evolution." Nature 422.6930 (2003): 428-33.
description	10.	Wilson, I A A. "Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution." Nature 289.5796 (1980): 366-73.
description	11.	Cobey, K. "Epochal Evolution Shapes the Phylodynamics of Interpandemic Influenza A (H3N2) in Humans." Science 314.5807 (2006): 1898-1903.
description	12.	Fitch, Walter M., Walter M. "Long term trends in the evolution of H(3) HA1 human influenza type A." Proceedings of the National Academy of Sciences of the United States of America 94.15 (1997): 7712-7718.
description	13.	Mager, D L L. "Bacteria and cancer: cause, coincidence or cure? A review." Journal of translational medicine 4.1 (2006): 14-14.
description	14.	Puig Barberà, J. "Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015." Vaccine 35.43: 5799-5807.
description	15.	Hillman, M. "Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control." Vaccine 20.25-26 (2002): 3068-3087.
description	16.	Wiley, D C C. "The structure and function of the hemagglutinin membrane glycoprotein of influenza virus." Annual Review of Biochemistry 56.1 (1987): 365-94.
description	17.	Patz, JA A. "Impact of regional climate change on human health." Nature 438.7066 (2005): 310-317.
description	18.	Jones, Kate E. "Global trends in emerging infectious diseases." Nature 451.7181 (2008): 990-993.
description	19.	Sridhar, S. "Longevity and Determinants of Protective Humoral Immunity Following Pandemic Influenza Infection." American journal of respiratory and critical care medicine 191.3 (2014): 325-332.
description	20.	Sun, X. "Detection of influenza A virus subtypes using a solid-phase PCR microplate chip assay." Journal of virological methods 211 (2015): 12-18.